exo-IWR-1
CAS No. 1127442-87-8
exo-IWR-1( —— )
Catalog No. M23321 CAS No. 1127442-87-8
exo-IWR-1 is an inactive stereoisomer of Endo-IWR-1,and is a negative control of IWR-1 (HY-12238).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 32 | In Stock |
|
| 25MG | 71 | In Stock |
|
| 50MG | 119 | In Stock |
|
| 100MG | 192 | In Stock |
|
| 200MG | 279 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Nameexo-IWR-1
-
NoteResearch use only, not for human use.
-
Brief Descriptionexo-IWR-1 is an inactive stereoisomer of Endo-IWR-1,and is a negative control of IWR-1 (HY-12238).
-
Descriptionexo-IWR-1 is an inactive stereoisomer of Endo-IWR-1,and is a negative control of IWR-1 (HY-12238). IWR-1 is a tankyrase inhibitor which inhibits Wnt/β-catenin signaling pathway.
-
In Vitroexo-IWR-1 (10 μM) does not influence the number of 293T cells infected with bunyaviruses.Exo-IWR-1 had no effect on RVFV MP12-GFP infection when cells were either pretreated or treated 1 hpi.
-
In Vivo——
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
Recptorwnt
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1127442-87-8
-
Formula Weight409.44
-
Molecular FormulaC25H19N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESC1[C@@H]2C=C[C@H]1[C@H]3[C@@H]2C(=O)N(C3=O)C4=CC=C(C=C4)C(=O)NC5=CC=CC6=C5N=CC=C6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Curcumol
Curcumol, a pure monomer isolated extracted from Rhizoma Curcumaeis, has antitumor activities.
-
TNIK-IN-7
TNIK-IN-7 is a potent and selective Traf2 and Nck interacting kinase (TNIK) inhibitor (IC50: 11 nM) with antitumor activity for studying signaling and proliferation in colorectal cancer cells.
-
JW 67
JW 67 is an inhibitor of canonical Wnt pathway signaling. JW 67 rapidly reduced active β-catenin with a subsequent downregulation of Wnt target genes, including AXIN2, SP5, and NKD1.
Cart
sales@molnova.com